Hepatocyte Deoxyribonucleic Acid (DNA) (DNA)

Hepatocyte Deoxyribonucleic Acid (DNA) refers to the complete genomic material within liver cells, which serves as the fundamental blueprint for hepatic metabolism, protein synthesis, and cellular regeneration. While not a single molecular target in the traditional sense, it is the primary site of action for transformative therapies including in vivo gene editing (e.g., CRISPR/Cas9) and gene replacement therapies delivered via viral vectors (Gillmore et al., 2021; Wang et al., 2019). In the context of chronic Hepatitis B, the persistence of viral DNA in the form of covalently closed circular DNA (cccDNA) within the hepatocyte nucleus represents a major therapeutic challenge and a target for novel curative strategies (Nassal, 2015). Furthermore, the accumulation of mutations within hepatocyte DNA is the driving force behind hepatocellular carcinoma, where DNA-intercalating agents or localized chemotherapy may be utilized. Because 'Hepatocyte DNA' encompasses the entire genome, therapeutic specificity is achieved by targeting particular gene sequences, such as the TTR gene for amyloidosis or the F8/F9 genes for hemophilia, to avoid widespread genotoxicity or off-target effects (Pasi et al., 2020).

Other names

Liver cell DNAHepatocyte genomeGenomic DNA of hepatocytes

Therapeutic strategies include CRISPR-Cas9 mediated gene editing to disrupt or correct specific sequences, AAV-mediated delivery of functional gene templates, and chemical intercalation to inhibit replication in malignant cells.